胰岛素降解酶(IDE)多克隆抗体
Polyclonal Antibody to Insulin Degrading Enzyme (IDE)
Insulysin; Insulin Protease; Abeta-degrading protease; Insulinase
- 编号PAB897Mu01
 - 物种Mus musculus (Mouse,小鼠)相同的名称,不同的物种。
 - 来源多抗制备
 - 宿主兔
 - 效价-
 - Ig类型IgG
 - 纯化方式抗原特异性亲和纯化
 - 标记物无标记物
 - 免疫原RPB897Mu01-胰岛素降解酶(IDE)重组蛋白
 - 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
 - 性状液体
 - 浓度500µg/mL
 - 且适物种Rattus norvegicus (Rat,大鼠)
 - 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载英文说明书 中文说明书
 - 规格20µl100µl200µl1ml10ml
 - 价格¥ 616¥ 1436¥ 2052¥ 5130¥ 20520
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
该抗体是针对IDE的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别IDE。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) | 
| RPB897Mu02 | 胰岛素降解酶(IDE)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB897Mu01 | 胰岛素降解酶(IDE)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB897Mu02 | 胰岛素降解酶(IDE)多克隆抗体 | WB; IHC | 
| PAB897Mu01 | 胰岛素降解酶(IDE)多克隆抗体 | WB; IHC; ICC; IP. | 
| SEB897Mu | 胰岛素降解酶(IDE)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB897Mu | 胰岛素降解酶(IDE)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
参考文献
| 杂志 | 参考文献 | 
| J Neurochem | Reduction[PubMed: 26442993] | 
| African Journal of Pharmacy and Pharmacology | Peptide hydroxamate derivatives as regulators for insulin receptor signaling and its degradation by zinc metalloprotease in diabetic rats[article-full-text-pdf] | 
| Biomedicine & Pharmacotherapy | Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylationin diabetic rats.[pubmed:27930980] | 
| Biological Trace Element Research | Nigella sativa Oil and Chromium Picolinate Ameliorate Fructose-Induced Hyperinsulinemia by Enhancing Insulin Signaling and Suppressing Insulin-Degrading Enzyme in Male Rats[10.1007/s12011-017-1167-z] | 
| Neuroscience | The Protective Effects of IGF-I against β-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A[Pubmed:29406271] | 





